newsfilter
← Latest News
GlobeNewswire·

Pliant Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

SOUTH SAN FRANCISCO, Calif., Sept. 30, 2024 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (NASDAQ:PLRX), today announced that on September 30, 2024 it granted stock options to purchase an aggregate of 120,000 shares of